clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT01215552 |
P6099 | clinical trial phase | phase I clinical trial | Q5452194 |
P582 | end time | 2010-11-01 | |
P4135 | maximum age | 80 | |
P2899 | minimum age | 55 | |
P1132 | number of participants | 3 | |
P4844 | research intervention | rolipram | Q410285 |
P6153 | research site | Brookhaven National Laboratory | Q585777 |
P580 | start time | 2010-09-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | A PET Study: Single-dose, Open-label Study of the Inhibition of [11C]R-rolipram Binding to Brain Phosphodiesterase - 4 (PDE-4) by HT-0712 |
Search more.